Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue
Breast cancer (BC) is a disease characterized by high degrees of heterogeneity at morphologic, genomic, and genetic levels, even within the same tumor mass or among patients. As a consequence, different subpopulations coexist and less represented clones may have a selective advantage, significantly...
Main Authors: | Tania Rossi, Giulia Gallerani, Giovanni Martinelli, Roberta Maltoni, Francesco Fabbri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/9/1242 |
Similar Items
-
Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient
by: Tania Rossi, et al.
Published: (2021-06-01) -
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer
by: Tania Rossi, et al.
Published: (2020-09-01) -
Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma
by: Andrew B Gill, et al.
Published: (2020-11-01) -
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis
by: Tania Rossi, et al.
Published: (2022-08-01) -
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
by: Hai‐Ming Huang, et al.
Published: (2021-02-01)